Vident Investment Advisory’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-112,737
Closed -$2.08M 1352
2021
Q4
$2.08M Buy
112,737
+4,382
+4% +$69.6K 0.05% 435
2021
Q3
$1.45M Buy
108,355
+2,101
+2% +$33.9K 0.04% 558
2021
Q2
$1.97M Sell
106,254
-3,252
-3% -$54.7K 0.06% 414
2021
Q1
$1.65M Buy
+109,506
New +$1.75M 0.06% 464
2015
Q4
Sell
-43,070
Closed -$534K 885
2015
Q3
$534K Buy
+43,070
New +$593K 0.07% 489

Other funds holding MDRX

Vident Investment Advisory's MDRX Position: Q1 2022 in Review

Vident Investment Advisory sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2022, closing a stake of 112,737 shares — an estimated $2.08M sold.

Vident Investment Advisory first reported a position in MDRX in Q3 2015 and held it in 5 quarters. The position peaked at $2.08M in Q4 2021. 256 funds tracked by Wall St. Rank hold MDRX as of Q1 2022.

  • Vident Investment Advisory reported no remaining Veradigm Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 112,737 Veradigm Inc. Common Stock shares in Q1 2022, an estimated $2.08M.
  • Vident Investment Advisory first reported a position in Veradigm Inc. Common Stock in Q3 2015 and held it in 5 quarters.
  • Vident Investment Advisory's Veradigm Inc. Common Stock position peaked at $2.08M in Q4 2021.
  • 256 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2022.

Based on Vident Investment Advisory's 13F filing for Q1 2022, filed 16 May 2022.